• 1
    The World Bank. Curbing the Epidemic. Governments and the Economics of Tobacco Control. Washington, DC: World Bank; 1999.
  • 2
    Chapman S., MacKenzie R. The global research neglect of unassisted smoking cessation: causes and consequences. PLoS Med 2010; 7: e1000216.
  • 3
    Ramstrom L., Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob Control 2006; 15: 2104.
  • 4
    Gilljam H., Galanti M. R. Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden. Addiction 2003; 98: 11839.
  • 5
    Stegmayr B., Eliasson M., Rodu B. The decline of smoking in northern Sweden. Scand J Public Health 2005; 33: 3214.
  • 6
    Lund K., Scheffels J., McNeill A. The association between use of snus and quit rates for smoking: results from seven Norwegian cross-sectional studies. Addiction 2011; 106: 1627.
  • 7
    Lund K. E., McNeill A., Scheffels J. The use of snus for quitting smoking compared with medicinal products. Nicotine Tob Res 2010; 12: 81722.
  • 8
    Zhu S. H., Wang J. B., Hartman A., Zhuang Y., Gamst A., Gibson J. T. et al. Quitting cigarettes completely or switching to smokeless tobacco: do US data replicate the Swedish results? Tob Control 2009; 18: 827.
  • 9
    Holm L. E., Fisker J., Larsen B. I., Puska P., Halldórsson M. Snus räddar inte liv – det gör bara rökstopp! [Snus does not save lives – only smoking cessation does that!]. Lakartidningen 2008; 105: 35012 [in Swedish.
  • 10
    Carter L. P., Stitzer M. L., Henningfield J. E., O'Connor R. J., Cummings K. M., Hatsukami D. K. Abuse liability assessment of tobacco products including potential reduced exposure products. Cancer Epidemiol Biomarkers Prev 2009; 18: 324162.
  • 11
    Gartner C. E., Hall W. H., Vos T. H., Bertram M. Y., Wallace A. L., Lim S. S. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet 2007; 369: 20104.
  • 12
    Royal College of Physicians. Harm reduction in nicotine addiction. Helping people who can't quit. A report by the Tobacco Advisory Group of the Royal College of Physicians. London: Royal College of Physicians; 2007.
  • 13
    European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Harm reduction: evidence, impacts and challenges. EMCDDA Scientific Monograph no. 10. Lisbon: EMCDDA; 2010.
  • 14
    Martinet Y., Fagerström K., McNeill A., Godfrey F. Harm reduction strategies for tobacco smoking: report from an ERS Research Seminar. Breath 2006; 2: 3023.
  • 15
    Wikmans T., Ramström L. Harm perception among Swedish daily smokers regarding nicotine, NRT-products and Swedish snus. Tob Induc Dis 2010; 8: 9.
  • 16
    Bansal M. A., Cummings K. M., Hyland A., Giovino G. A. Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them? Nicotine Tob Res 2004; 6: Suppl 3: S30310.